Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure

ClinicalTrials.gov ID: NCT05598333

Public ClinicalTrials.gov record NCT05598333. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 14, 2026, 5:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Adaptive, Double-blinded, Placebo Controlled, Randomized, Multi-center Trial to Evaluate the Efficacy, Safety and Tolerability of Intracoronary Infusion of AB-1002 in Adult Subjects With New York Heart Association (NYHA) Class III Heart Failure and Non-ischemic Cardiomyopathy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 2 adaptive, double-blinded, placebo-controlled, randomized, multi-center trial study to evaluate the safety and efficacy of a single dose of AB-1002, administered via antegrade intracoronary artery infusion, in males and females age \>18 years with non-ischemic cardiomyopathy and NYHA Class III symptoms of HF. Subjects will be randomized into one of three treatment groups in a 1:1:1

Study identification

NCT ID
NCT05598333
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
AskBio Inc
Industry
Enrollment
150 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 19, 2023
Primary completion
Oct 30, 2026
Completion
Dec 30, 2030
Last update posted
Dec 2, 2025

2023 – 2030

United States locations

U.S. sites
37
U.S. states
22
U.S. cities
34
Facility City State ZIP Site status
Cardiology P.C. Birmingham Birmingham Alabama 35211
University of Arizona Sarvor Heart Center Tucson Arizona 85724
University of California Irvine Medical Center Irvine California 92697
University of California San Diego La Jolla California 92093
University of California San Francisco San Francisco California 94143
Baycare Medical Group Clearwater Florida 33756
University of Miami Coral Gables Florida 33146
University of Florida Gainesville Florida 32610
Augusta University Augusta Georgia 30912
Loyola Medicine Burr Ridge Oakbrook Terrace Illinois 60181
University of Iowa Iowa City Iowa 52242
University of Kansas Medical Center (KUMC) Kansas City Kansas 66160
Massachusetts General Hospital Boston Massachusetts 02114
Brigham and Women's Hospital Boston Massachusetts 02115
Minneapolis Heart Institute Foundation Minneapolis Minnesota 55407
Mayo Clinic - Minnesota Rochester Minnesota 55905
Aurora Saint Luke's Health System Kansas City Missouri 64111
St. Louis University St Louis Missouri 63117
Renown Health Reno Nevada 89502
Morristown Medical Center - Cardiology Morristown New Jersey 07962
Mt. Sinai New York New York New York 10029
Stony Brook Stony Brook New York 11794
Montefiore Medical Center The Bronx New York 10461
Duke University Durham North Carolina 27705
The Christ Hospital / The Linder Center for Research Cincinnati Ohio 45219
University of Cincinnati Cincinnati Ohio 45219
MetroHealth Medical Center Cleveland Ohio 44109
The Ohio State University Columbus Ohio 43210
LVH Cardiology Allentown Pennsylvania 18103
Thomas Jefferson University Philadelphia Pennsylvania 19107
Medical University of South Carolina (MUSC) Medical Center Charleston South Carolina 29425
Stern Cardiovascular Germantown Tennessee 38138
Baylor Scott & White Advanced Heart Failure Clinic - Dallas Dallas Texas 75246
Baylor College of Medicine (BCM) - Baylor Heart Clinic Houston Texas 77030
Houston Methodist Debakey Cardiology Associates Houston Texas 77030
University of Washington Seattle Washington 98195
University of Wisconsin Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 59 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05598333, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 2, 2025 · Synced Sep 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05598333 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →